Home/Filings/4/0001127602-20-004591
4//SEC Filing

Lapuerta Pablo 4

Accession 0001127602-20-004591

CIK 0001062822other

Filed

Feb 9, 7:00 PM ET

Accepted

Feb 10, 4:07 PM ET

Size

7.6 KB

Accession

0001127602-20-004591

Insider Transaction Report

Form 4
Period: 2020-02-06
Lapuerta Pablo
SVP, Clin Dev and CMO
Transactions
  • Award

    Restricted Stock Units

    2020-02-06+82,41082,410 total
    Common Stock (82,410 underlying)
  • Award

    Stock Option (Right to Buy)

    2020-02-06+247,220247,220 total
    Exercise: $3.31Exp: 2030-02-06Common Stock (247,220 underlying)
Footnotes (3)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of common stock.
  • [F2]Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.
  • [F3]Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter.

Issuer

LEXICON PHARMACEUTICALS, INC.

CIK 0001062822

Entity typeother

Related Parties

1
  • filerCIK 0001516368

Filing Metadata

Form type
4
Filed
Feb 9, 7:00 PM ET
Accepted
Feb 10, 4:07 PM ET
Size
7.6 KB